|
|
Volumn 17, Issue 8, 2002, Pages 1537-
|
|
The use of statins after solid organ transplantation [5]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CALCINEURIN INHIBITOR;
CERIVASTATIN;
CYCLOSPORIN;
CYTOCHROME P450;
FLUINDOSTATIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
IMMUNOSUPPRESSIVE AGENT;
PLACEBO;
PRAVASTATIN;
TACROLIMUS;
PYRIDINE DERIVATIVE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG BLOOD LEVEL;
DRUG CROSS REACTIVITY;
DRUG EFFECT;
DRUG MARKETING;
DRUG METABOLISM;
DRUG SAFETY;
DRUG WITHDRAWAL;
FOLLOW UP;
HIGH RISK PATIENT;
HUMAN;
HYPERCHOLESTEROLEMIA;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
LETTER;
MAJOR CLINICAL STUDY;
MYOSITIS;
ORGAN TRANSPLANTATION;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
RHABDOMYOLYSIS;
RISK ASSESSMENT;
SURVIVAL RATE;
DRUG INTERACTION;
PHYSIOLOGY;
POSTOPERATIVE COMPLICATION;
DRUG INTERACTIONS;
HUMAN;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERCHOLESTEROLEMIA;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
POSTOPERATIVE COMPLICATIONS;
PYRIDINES;
HUMANS;
|
|
EID: 0036690246
PISSN: 09310509
EISSN: None
Source Type: Journal
DOI: 10.1093/ndt/17.8.1537 Document Type: Letter |
|
Times cited : (7)
|
|
References (4)
|
